WeBD.Tokyo
  • Home
  • Product
  • About
  • Contact
  • LinkedIn

md

Regulatory

Navigating the Japanese Pharmaceutical Market: A Strategic Guide for Foreign Companies

Expanding into the Japanese pharmaceutical market presents a wealth of opportunities for foreign companies, but it also comes with unique challenges. Regulatory complexities, language barriers, and the need for local expertise make market entry a daunting process. We have recently obtained MAH license for a licent, and would like to Read more…

By md, 2 monthsMarch 18, 2025 ago
Digitizing BD

Preview: Comprehensive list of Pharmaceutical companies in Japan

For non-Japanese biopharmaceutical companies looking to enter the Japanese market, the first challenge is often finding a comprehensive list of biopharma companies in Japan. While big names like Takeda or Astellas are well-known globally, many smaller, innovative players remain under the radar. These small-to-mid-size companies can offer unique partnership opportunities, Read more…

By md, 8 monthsOctober 1, 2024 ago

Recent Posts

  • Navigating the Japanese Pharmaceutical Market: A Strategic Guide for Foreign Companies
  • Preview: Comprehensive list of Pharmaceutical companies in Japan

Recent Comments

No comments to show.

Archives

  • March 2025
  • October 2024

Categories

  • Digitizing BD
  • Regulatory

WeBD.Tokyo is provided through a legal entity:
Dohi Inc. (Kanagawa, Japan)
# Corporate ID: 7021001076723


  • Home
Hestia | Developed by ThemeIsle